The Indian IPO market is buzzing with activity, and one of the most talked-about indicators for investors is the IPO GMP (Grey Market Premium). The GMP gives an unofficial idea of the market’s sentiment and the potential listing price of an IPO before it hits the stock exchanges.
In this blog, we’ll cover the latest GMP IPO updates, key subscription dates, and estimated listing prices for the ongoing and upcoming issues.
Live IPO GMP and Key Details
Here’s a snapshot of the latest IPOs in the market, their price bands, GMP, status, and estimated listing gains:
IPOs Closing Today (September 29, 2025)
Investors need to act quickly, as several IPOs are set to close today. These include:
-
Trualt Bioenergy IPO (Mainboard)
-
Jinkushal Industries IPO (Mainboard)
-
Chatterbox Technologies SME-IPO
-
Gujarat Peanut SME-IPO
-
Earkart SME-IPO
-
Telge Projects SME-IPO
These issues have received strong interest, and the IPO GMP suggests potential listing gains in some of them.
What is IPO GMP?
The IPO GMP or Grey Market Premium is the extra price at which shares of an IPO trade in the unofficial grey market before they are officially listed on the NSE or BSE.
-
Example: If an IPO is priced at ₹200 per share and the GMP is ₹50, the estimated listing price is ₹250.
-
It acts as a barometer of market demand and gives investors an idea of expected listing gains.
Important Note: The GMP IPO market is unofficial, unregulated, and highly speculative. It should not be the sole basis for making investment decisions. Investors should also study the company’s fundamentals, financials, and industry outlook before applying.
Conclusion
The IPO GMP trend shows strong investor appetite in ongoing and upcoming issues such as Trualt Bioenergy, Fabtech Technologies, and Advance Agrolife. While GMP can provide early insights into market sentiment, it remains volatile and speculative.
For smart investing, always combine GMP IPO data with company analysis and subscription trends. This balanced approach helps you make informed decisions and minimize risks.
Comments
0 comment